Alyeska Investment Group
MDCO

Alyeska Investment Group’s Medicines Co MDCO Stock Holding History

Alyeska Investment Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300,943
Closed -$25.6M – 538
2019
Q4 		$25.6M Buy
+300,943
New +$20.1M 0.34% 104

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Alyeska Investment Group's MDCO Position: Q1 2020 in Review

Alyeska Investment Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 300,943 shares — an estimated $25.6M sold.

Alyeska Investment Group first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $25.6M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Alyeska Investment Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 300,943 Medicines Co shares in Q1 2020, an estimated $25.6M.
  • Alyeska Investment Group first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Alyeska Investment Group's Medicines Co position peaked at $25.6M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.